MoU to strengthen biomedical science partnership
The Australian Institute of Medical Scientists (AIMS) and the UK Institute of Biomedical Science (IBMS) have signed a memorandum of understanding that is intended to strengthen the partnership between the two organisations for the benefit of members, the global biomedical science community and the profession.
AIMS President Robyn Wells and IBMS President Ian Sturdgess said in a joint statement that the agreement “follows a successful meeting in London that is the forerunner for closer ties and collaboration”.
According to AIMS CEO Edward Fraser, the vision of the agreement is to strengthen the profession in two leading nations in the medical science field and ensure global cross-fertilisation of ideas to improve health outcomes. As such, the agreement highlights a number of exciting areas for exploration, including membership, qualifications and the sharing of good practice guidance.
“The partnership with AIMS will ensure that the reach and relevance of biomedical science is felt beyond the two organisations and will facilitate recognition for laboratory professionals globally,” noted IBMS CEO Jill Rodney.
MV Hondius passengers return to Australia under strict infection control measures
The Australian CDC has provided an update on hantavirus risk to Australians and infection...
$96m RNA Research and Manufacturing Facility opens in NSW
The new 4500 sqm RNA Research and Manufacturing Facility within the Macquarie University...
Cartherics and Catalent announce enhanced partnership
To support immune cell therapy products for the treatment of cancer and endometriosis, Australian...
